Bionano Laboratories to Provide Enhanced Genetic Counseling and Patient Care for Genetic Disorders with OptraHEALTH’s HealthFAX™
September 26 2022 - 8:00AM
Bionano Laboratories and OptraHEALTH today announced their
collaboration to utilize HealthFAX’s proprietary AI platform to
enhance genetic counseling services and improve care for patients
receiving diagnostic services through the Bionano Laboratories.
Bionano Laboratories utilizes cutting-edge technologies to provide
genetic diagnostics in both clinical and research settings. Bionano
Laboratories intends to scale its operations while continuing to
improve the customer testing experience by adopting the HealthFAX
platform.
Within Bionano Laboratories’ new operational
workflow, patients seeking additional information surrounding
genetic disorders and testing services are sent a link to a custom
HealthFAX virtual assistant through the program’s ExpertConnect™
feature. This feature provides information to patients on the
genetic testing process and testing options and collects personal
and family history needed for future potential discussions with
genetic counselors. The approach will allow Bionano Laboratories to
automate parts of their up-front education workflows and reduce the
workload for their team, enabling Bionano Laboratories to
potentially service greater numbers of patients while providing
more efficient and effective customer care to their patients.
“We have chosen to incorporate the HealthFAX
platform into the Bionano Laboratories workflow with the intent to
increase operational efficiencies while also improving the overall
experience for our clients,” commented Erik Holmlin, PhD, president
and chief executive officer of Bionano Laboratories’ parent
company, Bionano Genomics. “With the implementation of these new
tools, Bionano Laboratories will be able to scale as it expands
services in the future.”
Dr. Gauri Naik, CEO of OptraHEALTH commented,
“OptraHEALTH aims to make HealthFAX widely accessible to all
families in need of more information about genetic testing for
autism spectrum and other genetic disorders. It is unimaginable how
much anxiety parents undergo while awaiting results for their
child’s genetic test. The HealthFAX conversational platform will
provide Bionano Laboratories with digital tools to better service
their patient community while providing live support at scale as
required.”
More information is available at:
https://bionanolaboratories.com/
About OptraHEALTH®:
OptraHEALTH® is focused on improving outcomes
for consumers and leading Life Sciences and Healthcare
organizations by utilizing its next-generation Artificial
Intelligence Platform. OptraHEALTH’s flagship product, HealthFAX™
Virtual Care Platform for Healthcare, is used in healthcare
settings for better engagement, experience, and education.
About Bionano Laboratories:
Lineagen, Inc., d/b/a Bionano Laboratories, a
subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) provides access
to genetic answers and support utilizing cutting-edge technologies
to advance the way you see the genome. Its clinical services
offer a genetic testing experience that combines a comprehensive
testing portfolio with thoughtful and accessible support options
for the diagnostic journey. Bionano Laboratories also offers direct
access to optical genome mapping for applications across basic,
translational and clinical research. For more information, visit
www.bionanolaboratories.com.
Forward-Looking Statements of
Bionano
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Words such as “may,” “can,” “believe” and
similar expressions (as well as other words or expressions
referencing future events, conditions or circumstances) convey
uncertainty of future events or outcomes and are intended to
identify these forward-looking statements. Forward-looking
statements include statements regarding our intentions, beliefs,
projections, outlook, analyses or current expectations concerning,
among other things, the benefits of HealthFAX and its platform to
genetic counseling services and patients, the benefits of HealthFAX
to Bionano Laboratories, its operations, its customer testing
experience and its workflows, the ability of Bionano Laboratories
to scale operations effectively with the use of HealthFAX and
OptraHEALTH’s ability to expand access to HealthFAX and provide
positive digital tools. Actual results or developments may differ
materially from those projected or implied in these forward-looking
statements. Factors that may cause such a difference include the
risks and uncertainties associated with: the impact of the COVID-19
pandemic on our respective businesses and the global economy;
general market conditions; changes in the competitive landscape and
the introduction of competitive technologies or improvements to
existing technologies; changes in our respective strategic and
commercial plans; our respective abilities to obtain sufficient
financing to fund our strategic plans and commercialization
efforts; and the risks and uncertainties associated with Bionano
Genomics’ business and financial condition in general, including
the risks and uncertainties described in its filings with
the Securities and Exchange Commission, including, without
limitation, its Annual Report on Form 10-K for the year
ended December 31, 2021 and in other filings subsequently
made by it with the Securities and Exchange Commission. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management’s assumptions and estimates as of such date. We do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACTSBionano Company
Contacts:Erik Holmlin, CEOBionano Genomics, Inc.+1 (858)
888-7610eholmlin@bionanogenomics.com
Investor Relations:Amy
ConradJuniper Point+1 (858) 366-3243amy@juniper-point.com
OptraHEALTH:Ashwin Kotwaliwale MD
Ph.D., Medical DirectorOptraHEALTHinfo@optrahealth.com
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Apr 2023 to Apr 2024